It has been reported that an inflammation-regulated transcription factor known as CCAAT-enhancer-binding protein (C/EBPβ) can modulate LGMN expression in the pathogenesis of Alzheimer’s disease (Wang et al., 2018). Here, CEBPB is linked to Alzheimer disease.